Pediatrix Medical (MD) Net Cash Flow (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Net Cash Flow data on file, last reported at -$169.5 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$169.5 million, down 30.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $105.4 million (up 2.37% YoY), and the FY2025 annual result was $145.3 million, down 13.18% from the prior year.
• Net Cash Flow declined to -$169.5 million in Q1 2026 per MD's latest filing, from $35.2 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $127.9 million in Q4 2024 and troughed at -$372.7 million in Q1 2022.
• A 5-year average of -$10.1 million and a median of $3.3 million in 2023 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow soared 4405.1% in 2023, then tumbled 1804.29% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $1.2 million in 2022, then soared by 4405.1% to $52.1 million in 2023, then surged by 145.6% to $127.9 million in 2024, then slumped by 72.49% to $35.2 million in 2025, then slumped by 581.67% to -$169.5 million in 2026.
• Business Quant data shows MD's Net Cash Flow at -$169.5 million in Q1 2026, $35.2 million in Q4 2025, and $115.3 million in Q3 2025.